Rice, Baylor researchers developing “glyco-immune” checkpoint inhibitor

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers from Rice University and Baylor College of Medicine have identified a “glyco-immune” checkpoint inhibitor that could help treat bone cancer metastasis for breast cancer survivors.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login